Is Anthropic’s IPO a Good Reason to Buy Ginkgo Bioworks Right Now?

Detailed summary
The AI developer's offering will give it a pile of cash that it might choose to spend on biomedical research automation.
Anthropic (ANT +0.00%) is planning to move forward with its initial public offering (IPO), with trading expected to begin Nov. 19. In doing so, the AI company will raise tens of billions of dollars, which it plans to spend on computing power and infrastructure. But with its focus increasingly turning toward orienting its AI capabilities toward bioscience, the next few years will likely see it make major investments to secure the ingredients it needs to test the hypotheses its AI proposes.
Chief among those ingredients are lab space and biomedical research equipment -- and, as it's a tech company bent on automation, laboratory robotics and other research automation solutions will be near the top of the list.
Enter Ginkgo Bioworks (DNA +1.44%), a lab-automation biotech and aspiring biomanufacturer that's already collaborating with Anthropic's biggest competitor, OpenAI. While many other businesses offer different components of an automated biopharma research stack, Ginkgo says its cart-based system is more modular, expandable, robust, and customizable than any competing platform on the market. So does Anthropic, and its soon-to-land massive pile of money make Ginkgo worth buying right now?
Ginkgo has a unique approach to developing a fully autonomous lab designed to handle multiple types of experiments with minimal hands-on time.
Its solution features a series of robotic carts, each with a central cabinet with an optional small sterile environment. They are connected so they can pass samples and data along after each experiment, while the software plans the next experiments. Humans set the system's goals and check its results. Each cart typically has at least one piece of laboratory hardware in its cabinet, such as a liquid-handling robot, a centrifuge, or an analyzer. Ginkgo's Nebula lab runs more than 100 of these reconfigurable carts.
OpenAI has already put one of its advanced models in charge of a Ginkgo lab.
In third-quarter 2026, Ginkgo said frontier AI labs also use…
Opening of the article, excerpted from The Motley Fool. To read the rest, open the article on the publisher's site.
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.fool.com)




